Literature DB >> 15976343

Polymorphism of the 5' flanking region of the IL-12 receptor beta2 gene partially determines the clinical types of leprosy through impaired transcriptional activity.

H Ohyama1, K Ogata, K Takeuchi, M Namisato, Y Fukutomi, F Nishimura, H Naruishi, T Ohira, K Hashimoto, T Liu, M Suzuki, Y Uemura, S Matsushita.   

Abstract

BACKGROUND: Individual differences in T cell responsiveness to interleukin 12 (IL-12), resulting from inherited factors, may be responsible for differences in the intensity of cell mediated immune (CMI) responses in patients with leprosy, a disease with a wide clinical spectrum. AIM: Polymorphisms in the 5' flanking region of the IL12RB2 gene were analysed to determine potential immunogenetic factors affecting CMI responses, using leprosy as a model.
METHODS: Polymorphisms in the 5' flanking region of IL12RB2 were examined using direct sequencing techniques, and allele frequencies between patients with lepromatous leprosy and patients with tuberculoid leprosy were compared. The effect of these single nucleotide polymorphisms (SNPs) on IL12RB2 expression was estimated using the dual luciferase reporter gene assay in Jurkat T cells.
RESULTS: Several SNPs, including -1035A>G, -1023A>G, -650delG, and -465A>G, were detected within the 5' flanking region of IL12RB2. The frequency of haplotype 1 (-1035A, -1023A, -650G, -464A) was high in the general Japanese population, but was significantly lower in lepromatous patients compared with tuberculoid patients and healthy controls. Reporter gene assays using Jurkat T cells revealed that all haplotypes carrying one or more SNP exhibited a lower transcriptional activity compared with haplotype 1.
CONCLUSION: SNPs within the 5' flanking region of IL12RB2 affect the degree of expression of this gene and may be implicated in individual differences in CMI responsiveness to mycobacterial antigens, leading to lepromatous or tuberculoid leprosy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976343      PMCID: PMC1770718          DOI: 10.1136/jcp.2004.023903

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  Biological function and distribution of human interleukin-12 receptor beta chain.

Authors:  C Y Wu; R R Warrier; D M Carvajal; A O Chua; L J Minetti; R Chizzonite; P K Mongini; A S Stern; U Gubler; D H Presky; M K Gately
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

Review 2.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

Authors:  G Trinchieri
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

3.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

4.  A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits.

Authors:  D H Presky; H Yang; L J Minetti; A O Chua; N Nabavi; C Y Wu; M K Gately; U Gubler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  Use of genetic profiling in leprosy to discriminate clinical forms of the disease.

Authors:  Joshua R Bleharski; Huiying Li; Christoph Meinken; Thomas G Graeber; Maria-Teresa Ochoa; Masahiro Yamamura; Anne Burdick; Euzenir N Sarno; Manfred Wagner; Martin Röllinghoff; Thomas H Rea; Marco Colonna; Steffen Stenger; Barry R Bloom; David Eisenberg; Robert L Modlin
Journal:  Science       Date:  2003-09-12       Impact factor: 47.728

6.  Association between IFNA genotype and the risk of sarcoidosis.

Authors:  Mitsuteru Akahoshi; Mami Ishihara; Natascha Remus; Kazuko Uno; Katsuhisa Miyake; Tomomitsu Hirota; Kazuko Nakashima; Akira Matsuda; Mizuo Kanda; Tadao Enomoto; Shigeaki Ohno; Hitoshi Nakashima; Jean-Laurent Casanova; Julian M Hopkin; Mayumi Tamari; Xiao-Quan Mao; Taro Shirakawa
Journal:  Hum Genet       Date:  2004-03-05       Impact factor: 4.132

Review 7.  Cytokine patterns at the site of mycobacterial infection.

Authors:  P A Sieling; R L Modlin
Journal:  Immunobiology       Date:  1994-10       Impact factor: 3.144

8.  IL-12 regulates T helper type 1 cytokine responses in human infectious disease.

Authors:  P A Sieling; X H Wang; M K Gately; J L Oliveros; T McHugh; P F Barnes; S F Wolf; L Golkar; M Yamamura; Y Yogi; K Uyemura; T H Rea; R L Modlin
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

9.  Selective primary health care: strategies for control of disease in the developing world. V. Leprosy.

Authors:  B R Bloom; T Godal
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

10.  Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells.

Authors:  S J Szabo; A S Dighe; U Gubler; K M Murphy
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  8 in total

1.  Characterization of an IL-12 p40/p35 Truncated Fusion Protein That can Inhibit the Action of IL-12.

Authors:  Denise Skrombolas; Isabel Wylie; Shivana Maharaj; John G Frelinger
Journal:  J Interferon Cytokine Res       Date:  2015-05-04       Impact factor: 2.607

Review 2.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

3.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

4.  Mycobacterium leprae actively modulates the cytokine response in naive human monocytes.

Authors:  Daniel Sinsimer; Dorothy Fallows; Blas Peixoto; James Krahenbuhl; Gilla Kaplan; Claudia Manca
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

5.  Functional analysis of differences in transcriptional activity conferred by genetic variants in the 5' flanking region of the IL12RB2 gene.

Authors:  Nahoko Kato-Kogoe; Hideki Ohyama; Soichiro Okano; Koji Yamanegi; Naoko Yamada; Masaki Hata; Hiroshi Nishiura; Yoshimitsu Abiko; Nobuyuki Terada; Keiji Nakasho
Journal:  Immunogenetics       Date:  2015-11-09       Impact factor: 2.846

6.  Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12Rβ2 promoter in Indian tuberculosis patients.

Authors:  Vikas Kumar Verma; Vibha Taneja; Anand Jaiswal; Sangeeta Sharma; Digamber Behera; Vishnubhatla Sreenivas; Shyam Singh Chauhan; Hanumanthappa Krishna Prasad
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

7.  Genome scan of M. tuberculosis infection and disease in Ugandans.

Authors:  Catherine M Stein; Sarah Zalwango; LaShaunda L Malone; Sungho Won; Harriet Mayanja-Kizza; Roy D Mugerwa; Dmitry V Leontiev; Cheryl L Thompson; Kevin C Cartier; Robert C Elston; Sudha K Iyengar; W Henry Boom; Christopher C Whalen
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

Review 8.  Pauci- and Multibacillary Leprosy: Two Distinct, Genetically Neglected Diseases.

Authors:  Jean Gaschignard; Audrey Virginia Grant; Nguyen Van Thuc; Marianna Orlova; Aurélie Cobat; Nguyen Thu Huong; Nguyen Ngoc Ba; Vu Hong Thai; Laurent Abel; Erwin Schurr; Alexandre Alcaïs
Journal:  PLoS Negl Trop Dis       Date:  2016-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.